Dietary Reference Intakes: Water, Potassium, Sodium, Chloride, and Sulfate
Pfizer emphasized that initial Phase-1 data (announced at an association meeting) showed MET-233i had a potential best-in-class profile ( [11] )
Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]
4 In addition, genetic and epigenetic changes to DNA can affect the ability of sperm to fertilize an egg and create a viable embryo
rather, the weight loss it enables triggers downstream changes in luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estrogen
This is called metabolic adaptation